Đang chuẩn bị liên kết để tải về tài liệu:
Systemic therapy for hepatocellular carcinoma: A reviewa

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

epatocellular carcinoma (HCC) is the most common type of primary liver cancer. Advanced HCC has poor prognosis with short survival rate. According to Barcelona Classification of Liver Cancer (BCLC), systemic therapy is optimal treatment for patients at this stage. In 2007, the targeted therapy with sorafenib was first approved to treat advanced HCC, which helps prolong survival of the patients. This article aims: To update the findings and application of adjuvant regimens for HCC. |

TÀI LIỆU LIÊN QUAN

Systemic therapy for hepatocellular carcinoma: A reviewa

Systemic therapy for hepatocellular carcinoma: a review

Summary of doctoral thesis: Characteristics of immune disorders and results of pulse methylprednisolone therapy in severe systemic lupus erythematosus

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma

Rationale and design of REGULATE: An observational study protocol for relationship between plasma metabolome and the efficacy of systemic glucocorticoid in acute exacerbation of chronic obstructive pulmonary disease

Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review

Cholesterol-conjugated let-7a mimics: Antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy

Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/ pleural metastases after a complete response to systemic therapy

Systemic therapy in younger and elderly patients with advanced biliary cancer: Subanalysis of ABC-02 and twelve other prospective trials
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.